Wright Bonilla Quoted on Isolation/Purification Distinction

05 August 2011 FDA Week News

Foley Partner Jacqueline Wright Bonilla was quoted in an article that appeared in FDA Week on August 5, 2011 titled "Gene Patent Ruling’s Isolation v. Purification Distinction Could Impact Biotech." Wright Bonilla discusses a federal court ruling on DNA patent eligibility that distinguishes between the terms isolation and purification. She states that the distinction is not clearly defined with regards to non-nucleic acid biologics and pharma molecules, adding that this distinction might be determined on a product-by-product basis and influence how attorneys draft their patent claims.

Insights

Botnet Infecting Content Management Systems (CMSes) of 100,000’s Websites!
27 October 2020
Internet, IT & e-Discovery Blog
Charitable Planning in the Midst of Uncertainty
27 October 2020
2020 Election Resource Center
Managing Warranty Disputes in the Age of COVID-19
27 October 2020
Coronavirus Resource Center:Back to Business
Podcast Episode 19: Stephen Jones, Associate
27 October 2020
Foley Career Perspectives